Navigation Links
Former Capital One Director and Business Leader Stanley I. Westreich Joins Neuralstem's Board
Date:2/15/2011

ROCKVILLE, Md., Feb. 15, 2011 /PRNewswire/ -- Neuralstem, Inc. (NYSE Amex: CUR) announces the appointment of business leader Stanley I. Westreich to its Board of Directors. With his appointment the company's board is now comprised of a majority of independent directors.

(Logo: http://photos.prnewswire.com/prnh/20061221/DCTH007LOGO)

Dr. Karl Johe, PhD, Chairman of Neuralstem's Board of Directors and the Company's Chief Science Officer, welcomed Mr. Westreich on behalf of the shareholders stating that, "Mr. Westreich is a welcome addition to our Board of Directors. His wealth of experience as a business and finance leader will be an excellent resource to our company."

"Neuralstem is an emerging leader in the field of regenerative medicine," said Mr. Westreich. "I look forward to working with this great organization as it grows."  

Richard Garr, Neuralstem's CEO and President, said, "We are honored to have Mr. Westreich on our board. This is a crucial time for Neuralstem as we transition through development stage to commercialization for both our cell therapy and small molecule programs. His insight and experience will be a welcome addition."

Mr. Westreich served as Director and Member of the Finance & Trust Oversight Committee of Capital One Financial Corp. and was a Director of Capital One Bank (USA) from 1994 through 2010. Mr. Westreich also served as Chairman of its Compensation Committee from March 1995 through April 2005, and continued as Member until 2009. Mr. Westreich founded and was president of Westfield Realty, Inc., a Washington, D.C. area commercial real estate finance, development and construction company, from 1965 to 2005. He holds a Juris Doctorate from New York University and a Bachelors of Business Administration from The University of Miami.

About Neuralstem

Neuralstem's patented technology enables t
'/>"/>

SOURCE Neuralstem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Former Cerner Chief Operating Officer Joins Netsmart Technologies Board of Directors
2. Former U.S. Congressman Curt Weldon to Represent Regenicin at 2011 Future of Financial Markets Conference in Mumbai
3. Edwin Rivera-Martinez, Former Chief of the FDA’s International Compliance Branch, Joins PAREXEL Consulting Strategic Compliance Team
4. Former FDA Inspectors Train Medical Device, Pharmaceutical Companies How to Comply with Latest FDA Expectations for Validation and Part 11
5. Heiner Dreismann, Ph.D., Former President of Roche Molecular Systems, Joins the HistoRx Board of Directors
6. Regenicin Names Former U.S. Marine Corp Operations Officer, Christopher Hadsall, Chief Operating Officer
7. Dismissal of Lawsuit by Former Officer Affirmed by Appellate Court
8. Former Fujifilm Medical Systems USA Executive John J. Weber Agrees to Join Regenicin™ as a Member of Its Board of Directors and Interim CFO
9. UPDATE: Appeal of Lawsuit by Former Chief Executive Officer- Reinstated; and Sanctions Order Vacated
10. Appeal of Lawsuit by Former Chief Executive Officer- Reinstated; and Sanctions Order Vacated
11. Axial Exchange Recruits Karen Evans, Former Fed CIO, to Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... A new research platform uses a ... tiny structures undergoing stress and heating, an ... designs for microelectronics and batteries., This new ... about how heating and the surface stress ... Researchers have discussed the merits of surface-stress ...
(Date:8/28/2014)... 2014  Next month, executives from clinical trial marketing firm ... beginning with Patient-Centered Clinical Trials 2014 , to be ... , September 4-5. Patient recruitment experts Bonnie A. ... will share insights on the benefits of employing an ... – from media to mobile apps – can be used ...
(Date:8/28/2014)... work by a Florida State University research team has ... your temperature, emit white light, and convert photon energy ... like a butterfly. , Biwu Ma, associate professor in ... FAMU-FSU College of Engineering, created the molecule in a ... discover that his creation has many other unique capabilities. ...
(Date:8/28/2014)... Boston, MA (PRWEB) August 28, 2014 ... of wholesale construction materials, selected SoundConnect ... of their cloud based audio and web conferencing ... configured to support PrimeSource’s employees’ needs. SoundConnect ... technologies. , PrimeSource Building Products will be ...
Breaking Biology Technology:New analytical technology reveals 'nanomechanical' surface traits 2New analytical technology reveals 'nanomechanical' surface traits 3BBK Worldwide Leads Sessions at Key September Events 2Novel 'butterfly' molecule could build new sensors, photoenergy conversion devices 2PrimeSource Chooses SoundConnect as Collaboration Provider 2
... Inc. (NYSE: TMO ) announced that it will ... at the Westin St. Francis,Hotel in San Francisco, Calif. ... 4:00 p.m. (PST)., Marijn E. Dekkers, president and ... overview of the company and discuss its,expectations for future ...
... Pafuramidine on Clinical Hold ... Schedule Zensana(TM) ... N.J., Dec. 28 Par,Pharmaceutical Companies, Inc. (NYSE: ... the,development status of its three, in-licensed, proprietary pipeline,products: ...
... from Faux Science, NORTH KINGSTOWN, R.I., Dec. ... Pain Society, Dominion Diagnostics sponsored an extensive,educational program ... Test, Which Patient and Discriminating Real Science from ... FCP, DAAPM. Dr.,Barkin is an Associate Professor, Faculty ...
Cached Biology Technology:Thermo Fisher Scientific to Present at the 26th Annual JPMorgan Healthcare Conference 2Strativa Pharmaceuticals, the Proprietary Products Division of Par Pharmaceutical, Provides an Update on Development Status of Pafuramidine and Other in-Licensed Products 2Strativa Pharmaceuticals, the Proprietary Products Division of Par Pharmaceutical, Provides an Update on Development Status of Pafuramidine and Other in-Licensed Products 3Strativa Pharmaceuticals, the Proprietary Products Division of Par Pharmaceutical, Provides an Update on Development Status of Pafuramidine and Other in-Licensed Products 4Strativa Pharmaceuticals, the Proprietary Products Division of Par Pharmaceutical, Provides an Update on Development Status of Pafuramidine and Other in-Licensed Products 5Arizona Pain Society and Dr. Robert Barkin, Rush University Medical Center, Present Program on Comprehensive Urine Drug Testing Sponsored by Dominion Diagnostics 2
(Date:8/29/2014)... A leading U.S. Ebola researcher from the University of Texas ... a blend of three monoclonal antibodies can completely protect monkeys ... days after infection, at a time when the disease is ... written an editorial for Nature discussing advances in ... Marburg virus are among the most deadly of pathogens, with ...
(Date:8/29/2014)... in German . ... is considered the oldest form of communication. Acting as ... example, the sexual attraction between males and females. Fish ... coordinate reproductive behavior in males and females. Scientists at ... Algarve in Faro, Portugal, and at the Max Planck ...
(Date:8/29/2014)... of the Tibetan plateau -- the largest topographic anomaly ... both its profound effect on climate and its reflection ... GSA Bulletin , Katharine Huntington and colleagues employ a ... modern and fossil snail shells to investigate the uplift ... , Views range widely on the timing of surface ...
Breaking Biology News(10 mins):Leading Ebola researcher at UTMB says there's an effective treatment for Ebola 2Ready for mating at the right time 2Ready for mating at the right time 3Snails tell of the rise and fall of the Tibetan Plateau 2Snails tell of the rise and fall of the Tibetan Plateau 3Snails tell of the rise and fall of the Tibetan Plateau 4Snails tell of the rise and fall of the Tibetan Plateau 5Snails tell of the rise and fall of the Tibetan Plateau 6Snails tell of the rise and fall of the Tibetan Plateau 7
... to life-threatening bleeding episodes is misdiagnosed in 15 per ... international research project led by a Queen,s professor. ... decision," says Maha Othman, a professor in the Department ... research project on the rare platelet type of von ...
... caching of whitebark pine seeds by the Clark,s nutcracker in ... regenerate populations of the imperiled conifer in most of its ... in the February issue of Science Findings , a ... Stationsuggests, for the first time, that the success of whitebark ...
... The Society for Neuroscience (SfN) has been ... create and maintain BrainFacts.org , a unique nonprofit ... and promise of brain research. With joint founding partners ... will launch the Web site in late spring 2012 ...
Cached Biology News:Conservation of whitebark pine may hinge on preservation of ponderosa 2Conservation of whitebark pine may hinge on preservation of ponderosa 3Society for Neuroscience awarded $1.53 million to create BrainFacts.org 2Society for Neuroscience awarded $1.53 million to create BrainFacts.org 3
Mouse monoclonal [6C3] to JAB1 ( Abpromise for all tested applications). entrezGeneID: 10987 SwissProtID: O15386...
Human TGF-beta RIIb Affinity Purified Polyclonal Ab...
Human FGF R2 (alpha isoforms) MAb (Clone 98706)...
dithiothreitol, sulfhydryl reducing agent, C4H10O2S2; MW: 154.24, 97% pure (minimum), CAS No: 27565-41-9, store at -20 C ...
Biology Products: